Craig Kessler

Clinical trials

• Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

  Principal investigator · Completed · Phase 3

  Octapharma

  2015–2018
• Biomarkers Serum Collection Methodology Pilot Study

  Principal investigator · Completed

  Georgetown University

  2010–2011
• Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

  Principal investigator · Terminated · Phase 2, Phase 3

  Georgetown University

  2006–2011